US Patent Issued to CODEX LABS on Nov. 4 for "Compositions and methods for treating and managing chronic inflammatory skin disorders" (California Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,675, issued on Nov. 4, was assigned to CODEX LABS Corp. (San Jose, Calif.).

"Compositions and methods for treating and managing chronic inflammatory skin disorders" was invented by Marc Cornell (San Jose, Calif.) and Barbara A. Paldus (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to compositions and methods for treating and managing symptoms associated with inflammatory skin disorders by applying a synergistic blend of plant-based actives containing at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; and (c) a biotech-derived Haberlea rhodopensis extract."

The ...